PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Cleveland Clinic announces updated findings in preventive breast cancer vaccine study

Data presented at Society for Immunotherapy of Cancer Annual Meeting

Cleveland Clinic announces updated findings in preventive breast cancer vaccine study
2024-11-08
(Press-News.org) November 8, 2024, CLEVELAND: Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

 

The study team found that the investigational vaccine was generally well tolerated and produced an immune response in most patients. The team described the side effects of the vaccine, showed the highest tolerated dose to date, and presented the immunologic effects of the vaccine. Findings are being presented at the Society for Immunotherapy of Cancer Annual Meeting.

 

Launched in 2021 and funded by the U.S. Department of Defense, the ongoing clinical trial is evaluating safety and monitoring immune response of the vaccine. The phase 1 study, conducted at Cleveland Clinic’s main campus in partnership with Anixa Biosciences, Inc., has included 26 patients to date across three cohorts:

Phase 1a - patients who completed treatment for early-stage, triple-negative breast cancer within the past three years and are currently tumor-free but at high risk for recurrence. Phase 1b - individuals who are cancer-free and at high risk for developing breast cancer who have elected to voluntarily have a preventative mastectomy to lower their risk. Primarily, these are women with BRCA1, BRCA2 and PALB2 mutations. Phase 1c - patients with early-stage triple-negative breast cancer who have received preoperative chemoimmunotherapy and surgery, and are being treated with pembrolizumab following surgery. These patients have residual cancer in the breast tissue, making them at risk of recurrence.
  Anixa is planning a phase 2 study to evaluate the efficacy of the vaccine. The trial is expected to begin in 2025 and is projected to last approximately two to three years.

 

“Triple-negative breast cancer is the form of the disease for which we have the least effective treatments,” said G. Thomas Budd, M.D., of Cleveland Clinic’s Cancer Institute and principal investigator of the phase 1 study. “Long term, we are hoping that this can be a true preventive vaccine that would be administered to individuals who are cancer-free to prevent them from developing this highly aggressive disease.”

 

According to Dr. Budd, there is a great need for improved treatments for triple-negative breast cancer, which does not have biological characteristics that typically respond to hormonal or targeted therapies. Despite representing only about 10-15% of all breast cancers, triple-negative breast cancer accounts for a disproportionately higher percentage of breast cancer deaths, according to American Cancer Society. It is twice as likely to occur in Black women, and approximately 70-80% of the breast tumors that occur in women with mutations in the BRCA1 gene are triple-negative breast cancer.

 

The investigational vaccine is based on pre-clinical research led by the late Vincent Tuohy, Ph.D., who was the Mort and Iris November Distinguished Chair in Innovative Breast Cancer Research at Cleveland Clinic’s Lerner Research Institute. Dr. Tuohy’s decades of groundbreaking research led to the development of this investigational vaccine. 

The vaccine targets a lactation protein, α-lactalbumin, which is no longer found after lactation in normal, aging breast tissues but is present in most triple-negative breast cancers. If breast cancer develops, the vaccine is designed to prompt the immune system to attack the tumor and keep it from growing. 

The study is based on Dr. Tuohy’s research that showed that activating the immune system against α-lactalbumin was safe and effective in preventing breast tumors in mice. The research, originally published in Nature Medicine, was funded in part by philanthropic gifts from more than 20,000 people over the last 12 years.

“It was Dr. Tuohy’s hope that this vaccine would demonstrate the potential of immunization as a new way to control breast cancer, and that a similar approach could someday be applied to other types of malignancy,” said Dr. Budd.

Anixa is the exclusive worldwide licensee of the novel breast cancer vaccine technology developed at Cleveland Clinic. Cleveland Clinic is entitled to royalties and other commercialization revenues from the company. 

For more information and eligibility requirements visit clinicaltrials.gov.

 

END

[Attachments] See images for this press release:
Cleveland Clinic announces updated findings in preventive breast cancer vaccine study

ELSE PRESS RELEASES FROM THIS DATE:

Intergenerational effects of adversity on mind-body health: Pathways through the gut-brain axis

2024-11-08
The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Intergenerational Effects of Adversity on Mind-Body Health: Pathways Through the Gut-Brain Axis” on Tuesday, November 12, 2024, at 2:00 pm ET. The presenter, Bridget Laura Callaghan, Ph.D., is an Assistant Professor in the Department of Psychology at the University of California, Los Angeles (UCLA). At UCLA, Dr. Callaghan directs the Brain & Body Lab in the Department of Psychology and also heads the Mental Disorders and Pain research theme at the Goodman Luskin Microbiome Center. The webinar host, Jeffrey Borenstein, M.D., is the President ...

Watch this elephant turn a hose into a sophisticated showering tool

Watch this elephant turn a hose into a sophisticated showering tool
2024-11-08
Tool use isn’t unique to humans. Chimpanzees use sticks as tools. Dolphins, crows, and elephants are known for their tool-use abilities, too. Now a report in the Cell Press journal Current Biology on November 8, 2024, highlights elephants’ remarkable skill in using a hose as a flexible shower head. As an unexpected bonus, researchers say they also have evidence that a fellow elephant knows how to turn the water off, perhaps as a kind of “prank.” “Elephants are amazing with hoses,” says Michael Brecht ...

Chimpanzees perform better on challenging computer tasks when they have an audience

Chimpanzees perform better on challenging computer tasks when they have an audience
2024-11-08
When people have an audience watching them, it can change their performance for better or worse. Now, researchers reporting in the Cell Press journal iScience on November 8 have found that chimpanzees’ performance on computer tasks is influenced by the number of people watching them. The findings suggest that this “audience effect” predates the development of reputation-based human societies, the researchers say. “It was very surprising to find that chimpanzees are affected in their task performance by ...

New medical AI tool identifies more cases of long COVID from patient health records

2024-11-08
KEY TAKEAWAYS Researchers from Mass General Brigham are leveraging artificial intelligence to help identify the signs of long COVID, track how different symptoms manifest over time, and eliminate alternative explanations for patients’ symptoms. The new approach suggests that 22.8% of the population experience the symptoms of long COVID, a figure that may paint a more realistic picture of the pandemic’s long-term toll. Through analyzing a patient’s history over time, this new AI tool ...

Heat waves and adverse health events among dually eligible individuals 65 years and older

2024-11-08
About The Study: In this time-series study, heat waves were associated with increased adverse health events among dually eligible individuals 65 years and older. Without adaptation strategies to address the health-related impacts of heat, dually eligible individuals are increasingly likely to face adverse outcomes.  Corresponding Author: To contact the corresponding author, Hyunjee Kim, PhD, email kihy@ohsu.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamahealthforum.2024.3884) Editor’s Note: Please ...

Catastrophic health expenditures for in-state and out-of-state abortion care

2024-11-08
About The Study: In this cross-sectional study of U.S. patients seeking abortion, many individuals and their households were estimated to incur catastrophic health expenditures, particularly those traveling from out of state. The financial and psychological burdens of abortion seeking have likely worsened after the Dobbs decision, as more people need to cross state lines to reach abortion care. The findings suggest expansion of insurance coverage to ensure equitable access to abortion care, irrespective of people’s state of residence, ...

State divorce laws, reproductive care policies, and pregnancy-associated homicide rates

2024-11-08
About The Study: In this cross-sectional study of pregnancy-associated homicide rates, barriers to divorce were associated with higher homicide rates and access to reproductive health care was associated with lower homicide rates. This study highlights the association between state legislation and pregnancy-associated homicide in the U.S., which is important information for policymakers.  Corresponding Author: To contact the corresponding author, Kaitlin M. Boyle, PhD, email kb49@mailbox.sc.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2024.44199) Editor’s ...

Emerging roles of high-mobility group box-1 in liver disease

Emerging roles of high-mobility group box-1 in liver disease
2024-11-08
Liver diseases, both acute and chronic, continue to pose significant clinical challenges due to high morbidity and mortality rates. Acute liver injury (ALI) caused by acetaminophen (APAP) overdose, hepatic ischemia-reperfusion injury (HIRI), and chronic conditions like nonalcoholic fatty liver disease (NAFLD) and alcohol-associated liver disease (ALD) are influenced by HMGB1-mediated pathways. HMGB1 is released from injured or necrotic liver cells and triggers inflammatory responses. Its circulating levels have been associated with disease severity in liver conditions, marking ...

Exploring the systematic anticancer mechanism in selected medicinal plants

2024-11-08
Cancer remains one of the leading global causes of mortality, with an estimated increase in cases due to lifestyle, environmental, and genetic factors. Despite advancements in treatment, cancer's complexity and the side effects of conventional therapies necessitate alternative approaches. Medicinal plants, long valued for their therapeutic properties, have shown promise in cancer treatment, attributed to their natural phytoconstituents. This review focuses on the anticancer mechanisms of specific medicinal plants and discusses their potential for future therapeutic development. Anticancer Mechanisms of Selected Medicinal Plants Medicinal plants exert anticancer ...

University of Cincinnati researchers pen editorial analyzing present, future of emergency consent in stroke trials

University of Cincinnati researchers pen editorial analyzing present, future of emergency consent in stroke trials
2024-11-08
The University of Cincinnati’s Yasmin Aziz, MD, and Joseph Broderick, MD, coauthored an editorial published Nov. 7 in the journal Neurology analyzing the current use and potential future of alternatives to traditional informed consent in acute stroke trials.    Patient informed consent is a crucial part of ethical clinical trial design and implementation, but time is of the essence for stroke trials. Approximately 2 million neurons die each minute they are deprived of oxygen, and patients are also sometimes incapacitated and therefore unable to consent ...

LAST 30 PRESS RELEASES:

Chemists create world’s thinnest spaghetti

Empowering neuroscience: Large open brain models released

From traditional to technological: Advancements in fresco conservation

Design and imagination as essential tools during the climate crisis

Innovating archaeology: HKU scholars utilize immersive 3D tech to document and study the human past

What's the story, morning glory?

The unsolved mystery sounds of the Southern Ocean #ASA187

These wild chimpanzees play as adults to better cooperate as a group

Physical activity and all-cause mortality by age in 4 multinational megacohorts

Prenatal diet and infant growth from birth to age 24 months

Obesity prevention at an early age

New method for designing artificial proteins

MSU expert: How AI can help people understand research and increase trust in science

​​​​​​​Urgent need to enable more farmers and contractors to revive England’s network of hedgerows

ASH inclusion program retained and engaged hematologists underrepresented in field, 20-year analysis shows

How anti-obesity drugs are linked to food waste

Discovery explains kidney damage caused by blood pressure drugs

NYU Langone performs world’s first fully robotic double lung transplant

APSS accepting sleep and circadian research abstracts and session proposals for SLEEP 2025 in Seattle

DNA repair: A look inside the cell’s ‘repair café’

Astronomers take the first close-up picture of a star outside our galaxy

Here’s something Americans agree on: Sports build character

Engineering nature’s blueprint: Dendron-based assemblies for chlorophyll’s materials

Study reveals how cell types shape human brain networks

New genetic explanation for heart condition revealed

Poor mental health linked to browsing negative content online

People with migraine at high risk of depression during pandemic

Climate-driven hazards increases risk for millions of coastal residents, study finds

Females sleep less, awaken more frequently than males

Most Americans want primary care providers to address mental health

[Press-News.org] Cleveland Clinic announces updated findings in preventive breast cancer vaccine study
Data presented at Society for Immunotherapy of Cancer Annual Meeting